126 related articles for article (PubMed ID: 483)
1. Complexation in formulation of parenteral solutions: solubilization of the cytotoxic agent hexamethylmelamine by complexation with gentisic acid species.
Kreilgård B; Higuchi T; Repta AJ
J Pharm Sci; 1975 Nov; 64(11):1850-5. PubMed ID: 483
[TBL] [Abstract][Full Text] [Related]
2. Parenteral formulation of hexamethylmelamine potentially suitable for use in man.
Ames MM; Kovach JS
Cancer Treat Rep; 1982 Jul; 66(7):1579-81. PubMed ID: 6807543
[TBL] [Abstract][Full Text] [Related]
3. Hexamethylmelamine and hexamethylmelamine hydrochloride.
van de Vaart-van Zutphen HP; Smulders CF; Renema J; Hulshoff A
Pharm Weekbl Sci; 1982 Apr; 4(2):25-31. PubMed ID: 6808457
[TBL] [Abstract][Full Text] [Related]
4. Prodrugs of hydroxymethylpentamethylmelamine: a principal active metabolite of the antineoplastic agent hexamethylmelamine.
Ghodrati F; Lavoie EJ
Drug Des Discov; 1994 Feb; 11(2):135-47. PubMed ID: 8075301
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of complexation and pH on solubilization.
Li P; Tabibi SE; Yalkowsky SH
J Pharm Sci; 1998 Dec; 87(12):1535-7. PubMed ID: 10189262
[TBL] [Abstract][Full Text] [Related]
6. Phase I and clinical pharmacological evaluation of a parenteral hexamethylmelamine formulation.
Ames MM; Richardson RL; Kovach JS; Moertel CG; O'Connell MJ
Cancer Res; 1990 Jan; 50(1):206-10. PubMed ID: 2104537
[TBL] [Abstract][Full Text] [Related]
7. Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.
Cumber AJ; Ross WC
Chem Biol Interact; 1977 Jun; 17(3):349-57. PubMed ID: 407012
[TBL] [Abstract][Full Text] [Related]
8. Micellar complexes of all-trans retinoic acid with polyvinylalcohol-nicotinoyl esters as new parenteral formulations in neuroblastoma.
Zuccari G; Bergamante V; Carosio R; Gotti R; Montaldo PG; Orienti I
Drug Deliv; 2009 May; 16(4):189-95. PubMed ID: 19241235
[TBL] [Abstract][Full Text] [Related]
9. Characterization of complexes between naftifine and cyclodextrins in solution and in the solid state.
Uzqueda M; Martín C; Zornoza A; Sánchez M; Martínez-Ohárriz MC; Vélaz I
Pharm Res; 2006 May; 23(5):980-8. PubMed ID: 16715388
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin.
Tommasini S; Calabrò ML; Raneri D; Ficarra P; Ficarra R
J Pharm Biomed Anal; 2004 Oct; 36(2):327-33. PubMed ID: 15496325
[TBL] [Abstract][Full Text] [Related]
11. Development of a parenteral formulation of trimelamol, a synthetic S-triazine carbinolamine-containing cytotoxic agent.
Gibson M; Denham AJ; Taylor PM; Payne NI
J Parenter Sci Technol; 1990; 44(6):306-13. PubMed ID: 2277318
[TBL] [Abstract][Full Text] [Related]
12. Solubilization and preformulation studies on PG-300995 (an anti-HIV drug).
Ran Y; Jain A; Yalkowsky SH
J Pharm Sci; 2005 Feb; 94(2):297-303. PubMed ID: 15570598
[TBL] [Abstract][Full Text] [Related]
13. Solubilization and dissolution of tamoxifen-hydroxybutenyl cyclodextrin complexes.
Buchanan CM; Buchanan NL; Edgar KJ; Lambert JL; Posey-Dowty JD; Ramsey MG; Wempe MF
J Pharm Sci; 2006 Oct; 95(10):2246-55. PubMed ID: 16886192
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
Parikh T; Sandhu HK; Talele TT; Serajuddin AT
Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
[TBL] [Abstract][Full Text] [Related]
15. Effect of γ-cyclodextrin on solubilization and complexation of irbesartan: influence of pH and excipients.
Muankaew C; Jansook P; Stefánsson E; Loftsson T
Int J Pharm; 2014 Oct; 474(1-2):80-90. PubMed ID: 25128698
[TBL] [Abstract][Full Text] [Related]
16. Solubilization and stabilization of the cytotoxic agent coralyne.
Cho MJ; Repta AJ; Cheng CC; Zee-Cheng KY; Higuchi T; Pitman IH
J Pharm Sci; 1975 Nov; 64(11):1825-30. PubMed ID: 481
[TBL] [Abstract][Full Text] [Related]
17. Solubilization of monovalent weak electrolytes by micellization or complexation.
He Y; Yalkowsky SH
Int J Pharm; 2006 May; 314(1):15-20. PubMed ID: 16580158
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical properties of two ethenzamide-gentisic acid cocrystal polymorphs: Drug release profiles, spectroscopic studies and theoretical calculations.
Sokal A; Pindelska E; Szeleszczuk L; Kolodziejski W
Int J Pharm; 2017 Apr; 522(1-2):80-89. PubMed ID: 28274662
[TBL] [Abstract][Full Text] [Related]
19. Thermal degradation of some parenteral solutions of reserpine. I. Effects of temperature, reserpine concentration, pH and buffer molarity.
Asker AF; Helal MA; Motawi MM
Pharmazie; 1973 Aug; 28(8):526-9. PubMed ID: 4784560
[No Abstract] [Full Text] [Related]
20. Drug solubilization by complexation.
Loftsson T
Int J Pharm; 2017 Oct; 531(1):276-280. PubMed ID: 28842309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
